Skip to content

A 4-Arm polyethylene-glycol-based multivalent galactoside disrupts Pseudomonas aeruginosa biofilm and restores antibiotic susceptibility.

Sep 2026 · Journal of materials chemistry. B · Vol 14, pp. 11551-11560 · 0 citations · 36 references
Medicine

TL;DR

Results indicate that 4-Arm-PEG-Gal significantly disrupts mature biofilm and is specifically recognized by the lectin LecA, and compared to the use of antibiotics alone, the combination of 4-Arm-PEG-Gal and TOB reduces antibiotic usage by 75% and additionally eradicates 73% of the bacteria within the biofilm.

Abstract

The formation of Pseudomonas aeruginosa (P. aeruginosa) biofilm significantly enhances bacterial resistance to antimicrobial agents and escape from the host immune system, making the treatment of related infections considerably more challenging. As a potential approach for anti-biofilm strategies, the inhibition of lectins often relies on multivalent interactions to enhance binding affinity between the inhibitor and its target. In this study, targeting the P. aeruginosa lectin LecA, we constructed a polyethylene glycol-based multivalent galactoside, termed 4-Arm-PEG-Gal, by modifying the termini of 4-Arm-PEG with galactosides specific to LecA. The results indicate that 4-Arm-PEG-Gal significantly disrupts mature biofilm and is specifically recognized by the lectin LecA. Compared to the use of antibiotics alone, the combination of 4-Arm-PEG-Gal and TOB reduces antibiotic usage by 75% and additionally eradicates 73% of the bacteria within the biofilm. Furthermore, in a model of chronic lung infection, the combination of 4-Arm-PEG-Gal and TOB cleared all bacteria from the lungs, significantly reduced the secretion of TNF-α and IL-6 in the lungs, and effectively ameliorated lung damage caused by bacterial infection.

View source

Similar papers

Sep 2026

Preparation and functional evaluation of an alginate-targeted monoclonal antibody against Pseudomonas aeruginosa.

Pseudomonas aeruginosa is a critical-priority pathogen responsible for life-threatening infections in immunocompromised individuals, yet its extensive antigenic heterogeneity has impeded the development of immunotherapeutics. Alginate, a structurally conserved surface polysaccharide that forms the backbone of the biofi...

Xiao-Tong Wang, Chan-Yuan Dai, Xiang Ji et al. · 0 citations
Review

Oligosaccharide-mediated modulation of Staphylococcus aureus biofilm formation and epithelial inflammatory responses

Staphylococcus aureus (S. aureus) is an important opportunistic pathogen whose treatment is increasingly complicated by antimicrobial resistance and persistent biofilm formation. Carbohydrate-based molecules, including non-digestible oligosaccharides (NDOs) and human milk oligosaccharides (HMOs), have gained attention...

Amirmohammad Afsharnia · 0 citations
Aug 2026

Design, synthesis, and evaluation of membrane-targeted resveratrol-antimicrobial peptide mimic conjugates for MRSA-infected wound healing.

Findings position resveratrol-antibacterial peptide mimic conjugates as a promising antimicrobial candidate for combating MRSA-associated wound infections and provide valuable insights for the development of novel antimicrobial agents.

Huixiao Fu, Jun-Hang Zhang, Wen-Qiang Huang et al. · 0 citations
Open access Aug 2026

Assessing Vancomycin‐Formyl Peptide Conjugate Binding to the Surface of Resistant Staphylococcus aureus via Flow Cytometry

Flow cytometry is used to quantify the binding of vancomycin=fPep conjugates to S. aureus clinical isolates and will assist in future studies to understand how attached fPeps and other immune signalling cargoes can stimulate innate immune cell activation leading to bacterial phagocytosis.

Winfrey P Y Hoo, Jemma Gullick, Ryan Leung et al. · 0 citations
Review Open access Jan 2026

Broadly Defined Antibiotic Adjuvants for Pseudomonas aeruginosa

Pseudomonas aeruginosa is a widely distributed opportunistic pathogen with multiple drug resistance, making it particularly challenging to treat in lower respiratory tract infections. Its resistance mechanisms are complex, including low outer‐membrane permeability, efflux pump overexpression, biofilm formation, and quo...

Zhi-Han Chen, Yufan Li, Yuan-Lin Song · 0 citations
Open access Sep 2026

Phage–Antibiotic–Peptide Synergy Overcomes Biofilm-Mediated Multidrug Resistance in Serratia marcescens

Background/Objectives: Serratia marcescens is an opportunistic pathogen that causes severe hospital-acquired infections, notable for its biofilm formation abilities and development of extensive antibiotic resistance. Here, we aim to evaluate the efficacy of bacteriophages, antibiotics, and antimicrobial peptides (BAP),...

Aryaan P. Duggal, Adit B. Alreja, Isha Vashee et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.